318
Participants
Start Date
January 26, 2016
Primary Completion Date
January 29, 2019
Study Completion Date
February 28, 2019
Emricasan (5 mg)
Subjects with Non-alcoholic Steatohepatitis (NASH) Fibrosis will be administered orally with emricasan (5 mg) twice a day.
Emricasan (50 mg)
Subjects with Non-alcoholic Steatohepatitis (NASH) Fibrosis will be administered orally with emricasan (50 mg) twice a day.
Placebo
Subjects with Non-alcoholic Steatohepatitis (NASH) Fibrosis will be administered orally with a matching placebo twice a day.
Mount Sinai Beth Israel Medical Center, New York
NYU Langone Medical Center, New York
Columbia University Medical Center (CUMC), New York
Weill Cornell Medical College, New York
Montefiore Medical Center, The Bronx
Northwell Health, Inc., Manhasset
Charité - Universitätsmedizin Berlin, Berlin
State University of New York, Buffalo
Hospital of the University of Pennsylvania, Philadelphia
Thomas Jefferson University, Philadelphia
Temple University Hospital, Philadelphia
Albert Einstein Medical Center, Philadelphia
Hospital Universitario de Donostia, Donostia / San Sebastian
Sibley Memorial Hospital, Washington D.C.
Howard University, Washington D.C.
Universitätsklinikum Hamburg Eppendorf, Hamburg
Walter Reed National Military Medical Center, Bethesda
Mercy Medical Center, Baltimore
McGuire VA Medical Center, Richmond
Digestive and Liver Disease Specialists, Norfolk
Bon Secours Richmond Health System, Newport News
Rex Healthcare, Raleigh
Duke University Medical Center, Duke South Clinics, Durham
Hospital Universitario de La Princesa, Madrid
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario La Paz, Madrid
Carolinas Healthcare System, Center for Liver Disease, Charlotte
Hospital Universitario Puerta de Hierro - Majadahonda, Majadahonda
Asheville Gastroenterology Associates, PA, Asheville
Medical University of South Carolina, Charleston
PMG Research at Charleston, Charleston
iResearch Atlanta LLC, Decatur
Gastrointestinal Specialists of Georgia, Marietta
Medizinische Hochschule Hannover, Hanover
UF Hepatology Research at CTRB, Gainesville
Florida Hospital Orlando Transplant Institute, Orlando
Miami Veterans Administration Healthcare System, Miami
University of Miami/Schiff Center for Liver Diseases, Miami
Tampa General Medical Group, Tampa
Florida Digestive Health Specialist, Lakewood Rch
University of Alabama at Birmingham, Birmingham
Vanderbilt University Medical Center - Digestive Disease Center, Nashville
ClinSearch, LLC, Chattanooga
Methodist University Hospital, Memphis
Gastro One, Germantown
Hospital Universitario Marques de Valdecilla, Santander
University of Louisville, Louisville
University Hospitals Case Medical Center, Cleveland
Consultants for Clinical Research, Cincinnati
Hospital Clinico Universitario de Valencia, Valencia
Hospital General Universitario de Valencia, Valencia
Aquiant Research, New Albany
Universitätsklinikum Münster, Münster
Henry Ford Health System, Detroit
UnityPoint Clinic Center For Liver Disease, Des Moines
Iowa Digestive Disease Center, P.C, Clive
Universitätsklinikum der RWTH Aachen, Aachen
Universitätsklinikum Bonn, Bönning
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz
Mayo Clinic, Rochester
Northwestern Memorial Hospital, Chicago
Rush University Medical Center, Chicago
The University of Chicago Medical Center, Chicago
Washington University School of Medicine-Infectious Disease Clinical Research Unit, St Louis
Kansas City VA Medical Center, Kansas City
Kansas City Research Institute, Kansas City
Ochsner Clinic Foundation, New Orleans
Louisiana Research Center, LLC, Shreveport
Preferred Research Partners, Inc., Little Rock
Options Health Research, LLC, Tulsa
University of Texas Southwestern Medical Center, Dallas
Texas Clinical Research Institute, Arlington
Baylor All Saints Medical Center, Fort Worth
Baylor College of Medicine, Houston
Liver Associates of Texas, P.A., Houston
Research Specialists of Texas, Houston
American Research Corporation at the Texas Liver Institue, San Antonio
Brooke Army Medical Center, San Antonio
Pinnacle Clinical Research, PLLC, Live Oak
Universitätsklinikum Freiburg, Freiburg im Breisgau
University of Utah Health Sciences Center, Salt Lake City
University of Arizona Clinical and Translational Sciences Research Center, Tucson
UCLA The Pfleger Liver Institute, Los Angeles
Cedars Sinai Medical Center, West Hollywood
Gastrointestinal Biosciences, Los Angeles
California Liver Research Institute, Pasadena
University of California San Diego Medical Center, San Diego
Inland Empire Liver Foundation, Rialto
Surinder Singh Saini, M.D., Inc., Newport Beach
Fresno Clinical Research Center, Freestone
University of California Davis Medical Center, Sacramento
University of Washington Harborview Medical Center, Seattle
Yale University School of Medicine, New Haven
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Lahey Clinic Medical Center, Burlington
Doctors Office Center, Newark
University Gastroenterology, Providence
University of Vermont, Burlington
Eugastro GmbH, Leipzig
Hospital Universitario Vall d'Hebron, Barcelona
Hospital Clinic de Barcelona, Barcelona
Lead Sponsor
Conatus Pharmaceuticals Inc.
INDUSTRY